BioXcel Therapeutics Inc. (BTAI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioXcel Therapeutics Inc.

    NASDAQ: BTAI · Real-Time Price · USD
    3.79
    0.22 (6.16%)
    At close: Sep 05, 2025, 3:59 PM
    3.88
    2.37%
    After-hours: Sep 05, 2025, 07:55 PM EDT

    BioXcel Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.27M 1.38M 375K n/a
    Cost of Revenue
    		 2.14M 1.26M 20K 297K
    Gross Profit
    		 123K 120K 355K -297K
    Operating Income
    		 -67.25M -171.78M -159.65M -106.94M
    Interest Income
    		 2.6M 5.65M 2.53M 4K
    Pretax Income
    		 -59.6M -179.05M -165.76M -106.93M
    Net Income
    		 -59.6M -179.05M -165.76M -106.63M
    Selling & General & Admin
    		 34.49M 83.41M 68.76M 54.23M
    Research & Development
    		 30.43M 84.33M 91.24M 52.71M
    Other Expenses
    		 2.44M 4.16M n/a n/a
    Operating Expenses
    		 67.37M 171.9M 160M 106.94M
    Interest Expense
    		 15.13M 13.31M 8.21M 40K
    Selling & Marketing Expenses
    		 1.39M 19.9M 13.01M n/a
    Cost & Expenses
    		 69.51M 173.16M 160.02M 106.94M
    Income Tax Expense
    		 n/a n/a n/a -301K
    Shares Outstanding (Basic)
    		 2.54M 29.13M 28.02M 26.37M
    Shares Outstanding (Diluted)
    		 2.54M 29.13M 28.02M 26.37M
    EPS (Basic)
    		 -23.51 -6.15 -6.13 -4.04
    EPS (Diluted)
    		 -23.51 -6.15 -6.13 -4.04
    EBITDA
    		 -44.16M -165.42M -157.38M -107M
    EBIT
    		 -44.47M -165.74M -157.54M -107.29M
    Depreciation & Amortization
    		 309K 318K 327K 297K

    Add to Watchlist